These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9580049)
1. Use of ion trap gas chromatography-tandem mass spectrometry for detection and confirmation of anabolic substances at trace levels in doping analysis. Muñoz-Guerra J; Carreras D; Soriano C; Rodríguez C; Rodríguez AF J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):129-41. PubMed ID: 9580049 [TBL] [Abstract][Full Text] [Related]
2. Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option. Silva AI; Pereira HM; Casilli A; Conceição FC; Aquino Neto FR J Chromatogr A; 2009 Apr; 1216(14):2913-22. PubMed ID: 19013575 [TBL] [Abstract][Full Text] [Related]
3. Screening for anabolic steroids in doping analysis by liquid chromatography/electrospray ion trap mass spectrometry. Deventer K; Eenoo PV; Delbeke FT Biomed Chromatogr; 2006 May; 20(5):429-33. PubMed ID: 16177960 [TBL] [Abstract][Full Text] [Related]
4. Use of ion trap gas chromatography-multiple mass spectrometry for the detection and confirmation of 3'hydroxystanozolol at trace levels in urine for doping control. Mateus-Avois L; Mangin P; Saugy M J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):193-201. PubMed ID: 15664350 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous doping analysis of main urinary metabolites of anabolic steroids in horse by ion-trap gas chromatography-tandem mass spectrometry. Yamada M; Aramaki S; Kurosawa M; Kijima-Suda I; Saito K; Nakazawa H Anal Sci; 2008 Sep; 24(9):1199-204. PubMed ID: 18781036 [TBL] [Abstract][Full Text] [Related]
6. Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry. Schänzer W; Delahaut P; Geyer H; Machnik M; Horning S J Chromatogr B Biomed Appl; 1996 Dec; 687(1):93-108. PubMed ID: 9001957 [TBL] [Abstract][Full Text] [Related]
7. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. Schänzer W; Guddat S; Thomas A; Opfermann G; Geyer H; Thevis M Drug Test Anal; 2013; 5(11-12):810-8. PubMed ID: 23873860 [TBL] [Abstract][Full Text] [Related]
8. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Pozo OJ; Van Eenoo P; Deventer K; Lootens L; Grimalt S; Sancho JV; Hernández F; Meuleman P; Leroux-Roels G; Delbeke FT Steroids; 2009 Oct; 74(10-11):837-52. PubMed ID: 19464304 [TBL] [Abstract][Full Text] [Related]
9. Gas chromatographic quadrupole time-of-flight full scan high resolution mass spectrometric screening of human urine in antidoping analysis. Abushareeda W; Lyris E; Kraiem S; Wahaibi AA; Alyazidi S; Dbes N; Lommen A; Nielen M; Horvatovich PL; Alsayrafi M; Georgakopoulos C J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():74-83. PubMed ID: 28850889 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control. Mitrevski BS; Wilairat P; Marriott PJ J Chromatogr A; 2010 Jan; 1217(1):127-35. PubMed ID: 19931865 [TBL] [Abstract][Full Text] [Related]
11. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control. Balcells G; Matabosch X; Ventura R Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936 [TBL] [Abstract][Full Text] [Related]
12. Comparison of sensitivity between gas chromatography-low-resolution mass spectrometry and gas chromatography-high-resolution mass spectrometry for determining metandienone metabolites in urine. Kokkonen J; Leinonen A; Tuominen J; Seppälä T J Chromatogr B Biomed Sci Appl; 1999 Nov; 734(2):179-89. PubMed ID: 10595716 [TBL] [Abstract][Full Text] [Related]
13. Degradation of methyltestosterone in urine samples. Schweizer Grundisch C; Baume N; Saugy M Drug Test Anal; 2014; 6(11-12):1170-3. PubMed ID: 25516451 [No Abstract] [Full Text] [Related]
14. Non-targeted acquisition strategy for screening doping compounds based on GC-EI-hybrid quadrupole-Orbitrap mass spectrometry: A focus on exogenous anabolic steroids. de Albuquerque Cavalcanti G; Rodrigues LM; Dos Santos L; Zheng X; Gujar A; Cole J; Padilha MC; de Aquino Neto FR Drug Test Anal; 2018 Mar; 10(3):507-517. PubMed ID: 28600878 [TBL] [Abstract][Full Text] [Related]
15. Detection of anabolic steroids in head hair. Deng XS; Kurosu A; Pounder DJ J Forensic Sci; 1999 Mar; 44(2):343-6. PubMed ID: 10097359 [TBL] [Abstract][Full Text] [Related]
16. Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry. Tudela E; Deventer K; Van Eenoo P J Chromatogr A; 2013 May; 1292():195-200. PubMed ID: 23374366 [TBL] [Abstract][Full Text] [Related]
17. Short-column gas chromatography/tandem mass spectrometry for the detection of underivatized anabolic steroids in urine. Rossi SA; Johnson JV; Yost RA Biol Mass Spectrom; 1994 Mar; 23(3):131-9. PubMed ID: 8148403 [TBL] [Abstract][Full Text] [Related]
18. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control. Wang Z; Zhou X; Liu X; Dong Y; Zhang J J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983 [TBL] [Abstract][Full Text] [Related]
19. Screening of anabolic steroids in horse urine by liquid chromatography-tandem mass spectrometry. Yu NH; Ho EN; Leung DK; Wan TS J Pharm Biomed Anal; 2005 Apr; 37(5):1031-8. PubMed ID: 15862683 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of World Anti-Doping Agency criteria for anabolic agent analysis by using comprehensive two-dimensional gas chromatography-mass spectrometry. Mitrevski BS; Wilairat P; Marriott PJ Anal Bioanal Chem; 2010 Apr; 396(7):2503-11. PubMed ID: 20091298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]